keyword
https://read.qxmd.com/read/38691889/discovery-of-potent-and-novel-dual-nampt-brd4-inhibitors-for-efficient-treatment-of-hepatocellular-carcinoma
#1
JOURNAL ARTICLE
Chunjia Yin, Shuting Jia, Xiaojuan Yang, Liqiang Wu
The NAPRT-induced increase in NAD+ levels was proposed as a mechanism contributing to hepatocellular carcinoma (HCC) resistance to NAMPT inhibitors. Thus, concurrently targeting NAMPT and NAPRT could be considered to overcome drug resistance. A BRD4 inhibitor downregulates the expression of NAPRT in HCC, and the combination of NAMPT inhibitors with BRD4 inhibitors simultaneously blocks NAD+ generation via salvage and the PH synthesis pathway. Moreover, the combination of the two agents significantly downregulated the expression of tumor-promoting genes and strongly promoted apoptosis...
April 26, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38691868/ep300-through-upregulating-the-expression-of-vimentin-to-promote-the-progression-of-chordoma
#2
JOURNAL ARTICLE
Lingzhi Wen, Bin Xie, Hui Li, Jun Huang, Ying Shi, Yongguang Tao, Yuanbing Chen
OBJECTIVE: There is a lack of effective drugs to treat the progression and recurrence of chordoma, which is widely resistant to treatment in chemotherapy. The authors investigated the functional and therapeutic relevance of the E1A-binding protein p300 (EP300) in chordoma. METHODS: The expression of EP300 and vimentin was examined in specimens from 9 patients with primary and recurrent chordoma with immunohistochemistry. The biological functions of EP300 were evaluated with Cell Counting Kit-8, clonogenic assays, and transwell assays...
May 2024: Neurosurgical Focus
https://read.qxmd.com/read/38691867/the-role-of-systemic-therapy-in-advanced-skull-base-chordomas-overview-of-the-current-state-and-the-md-anderson-protocol
#3
JOURNAL ARTICLE
Matei A Banu, Shaan M Raza, Misha Amini, Scott Seaman, Franco Rubino, Rita Snyder, Shreyaskumar Patel, Franco DeMonte, Anthony P Conley
The role of systemic therapy in primary or advanced and metastatic chordoma has been traditionally limited because of the inherent resistance to cytotoxic therapies and lack of specific or effective therapeutic targets. Despite resection and adjuvant radiation therapy, local recurrence rates in clival chordoma remain high and the risk of systemic metastases is not trivial, leading to significant morbidity and mortality. Recently, molecular targeted therapies (MTTs) and immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic avenues in chordoma...
May 2024: Neurosurgical Focus
https://read.qxmd.com/read/38691784/assessment-of-antimicrobial-drugs-employed-at-government-operated-hospitals-in-central-and-northern-provinces-of-iraq
#4
JOURNAL ARTICLE
Mahmood Jawad, Shathel Khalaf Noman, Mohammed Rasool
OBJECTIVE: Aim: To document the clinical patterns of antibiotic prescriptions in government hospitals, where the majority of physicians possess a degree-based training. PATIENTS AND METHODS: Materials and Methods: A Retrospective cross section study carried out between 1/7/2022 and April 2023 that enrolling 300 patients from governmental hospitals from different provinces of Central and northern Iraq. The research form contained 15 fields divided into three sections...
2024: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/38691666/drug-promotions-between-ethics-regulations-and-financial-interests
#5
REVIEW
Vasile Astărăstoae, Liliana M Rogozea, Florin Gabriel Leaşu, Stefan Roşca
BACKGROUND: The promotion of the latest medicines produced by the pharmaceutical industry is an important issue both from an ethical point of view (the level of accessibility, the way research is carried out) and from the point of view of marketing and especially from the lobbying issues raised. AREAS OF UNCERTAINTY: The ethical dilemmas raised by the promotion of new drugs revolve between the need to discover new molecules important for treating a wide range of diseases and the need to establish a battery of ethical rules, absolutely necessary for regulations in the field to be compliant with all ethical principles...
May 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38691664/effectiveness-of-nirmatrelvir-ritonavir-for-the-prevention-of-covid-19-related-hospitalization-and-mortality-a-systematic-literature-review
#6
JOURNAL ARTICLE
Ashley S Cha-Silva, Meghan B Gavaghan, Tobias Bergroth, Ronika Alexander-Parrish, Jingyan Yang, Florin Draica, Jaymin Patel, Denise A Garner, Richard H Stanford, Genevieve Meier, John M McLaughlin, Jennifer L Nguyen
BACKGROUND: Nirmatrelvir/ritonavir (NMV/r) is an oral antiviral drug used to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in patients aged 12 years or older at high risk of progression to severe disease (eg, hospitalization and death). Despite being the preferred option for outpatient treatment in the majority of countries worldwide, NMV/r is currently underutilized in real-world clinical practice. AREAS OF UNCERTAINTY: As numerous real-world studies have described patient outcomes following treatment with NMV/r, this systematic literature review provides a comprehensive summary of evidence on NMV/r effectiveness against hospitalization and mortality further organized by clinically meaningful categories, such as acute versus longer-term follow-up, age, underlying health conditions, and vaccination status, to help inform health care decision making...
May 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38691646/intravenous-acetaminophen-ibuprofen-combogesic-iv
#7
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 29, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38691482/therapeutic-drug-monitoring-of-levetiracetam-in-different-trimesters-of-pregnant-women-with-epilepsy-in-a-tertiary-care-center-a-prospective-study
#8
JOURNAL ARTICLE
J Kumaravel, Phulen Sarma, Vanita Suri, Parampreet Singh, Ajay Prakash, Bikash Medhi
BACKGROUND: Levetiracetam is the most commonly used antiepileptic drug in pregnant women due to its low teratogenic risk profile, favorable pharmacokinetic characteristics, and safety profile. Serum levels of levetiracetam vary in epilepsy during pregnancy. Therefore, the aim of the study was to evaluate the serum levels of levetiracetam during different trimesters of pregnancy by using therapeutic drug monitoring (TDM). MATERIALS AND METHODS: This was a single-center, prospective study...
March 1, 2024: Neurology India
https://read.qxmd.com/read/38691440/antibiotic-dose-and-nutrient-availability-differentially-drive-the-evolution-of-antibiotic-resistance-and-persistence
#9
JOURNAL ARTICLE
Etthel M Windels, Lloyd Cool, Eline Persy, Janne Swinnen, Paul Matthay, Bram Van den Bergh, Tom Wenseleers, Jan Michiels
Effective treatment of bacterial infections proves increasingly challenging due to the emergence of bacterial variants that endure antibiotic exposure. Antibiotic resistance and persistence have been identified as two major bacterial survival mechanisms, and several studies have shown a rapid and strong selection of resistance or persistence mutants under repeated drug treatment. Yet, little is known about the impact of the environmental conditions on resistance and persistence evolution, and the potential interplay between both phenotypes...
May 1, 2024: ISME Journal
https://read.qxmd.com/read/38691357/adverse-pregnancy-outcomes-and-subsequent-first-time-use-of-psychiatric-treatment-among-fathers-in-denmark
#10
JOURNAL ARTICLE
Frederik Christiansen, Janne Petersen, Ida Holte Thorius, Agnes Ladelund, Espen Jimenez-Solem, Merete Osler, Mikkel Zöllner Ankarfeldt
IMPORTANCE: Becoming a first-time parent is a major life-changing event and can be challenging regardless of the pregnancy outcome. However, little is known how different adverse pregnancy outcomes affect the father's risk of psychiatric treatment post partum. OBJECTIVE: To examine the associations of adverse pregnancy outcomes with first-time psychiatric treatment in first-time fathers. DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study covered January 1, 2008, to December 31, 2017, with a 1-year follow-up completed December 31, 2018...
May 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38691296/real-world-evidence-of-folfiri-combined-with-anti-angiogenesis-inhibitors-or-anti-egfr-antibodies-for-patients-with-early-recurrence-colorectal-cancer-after-adjuvant-folfox-capox-therapy-a-japanese-claims-database-study
#11
JOURNAL ARTICLE
Yoshinori Kagawa, Chaochen Wang, Yongzhe Piao, Long Jin, Yoshinori Tanizawa, Zhihong Cai, Yu Sunakawa
BACKGROUND: Oxaliplatin-containing adjuvant regimens (folinic acid, fluorouracil, and oxaliplatin/capecitabine and oxaliplatin [FOLFOX/CAPOX]) are used after curative resection of colorectal cancer (CRC). However, real-world evidence regarding treatment sequences and outcomes in patients with early recurrence CRC after adjuvant chemotherapy is limited. OBJECTIVE: We aimed to describe the patient characteristics, treatment sequence, and overall duration of second-line (2L) therapy in patients with early recurrence CRC who received adjuvant chemotherapy (FOLFOX/CAPOX) followed by folinic acid, fluorouracil, and irinotecan (FOLFIRI) + anti-angiogenesis drugs (AA) or FOLFIRI + anti-epidermal growth factor receptor (EGFR) antibodies...
May 1, 2024: Targeted Oncology
https://read.qxmd.com/read/38691254/novel-loading-protocol-combines-highly-efficient-encapsulation-of-exogenous-therapeutic-toxin-with-preservation-of-extracellular-vesicles-properties-uptake-and-cargo-activity
#12
JOURNAL ARTICLE
Stefania Zuppone, Natasa Zarovni, Kosuke Noguchi, Francesca Loria, Carlo Morasso, Andres Lõhmus, Ikuhiko Nakase, Riccardo Vago
Extracellular vesicles (EVs) have mostly been investigated as carriers of biological therapeutics such as proteins and RNA. Nevertheless, small-molecule drugs of natural or synthetic origin have also been loaded into EVs, resulting in an improvement of their therapeutic properties. A few methods have been employed for EV cargo loading, but poor yield and drastic modifications of vesicles remain unsolved challenges. We tested a different strategy based on temporary pH alteration through incubation of EVs with alkaline sodium carbonate, which resulted in conspicuous exogenous molecule incorporation...
April 30, 2024: Discov Nano
https://read.qxmd.com/read/38691241/identification-of-potential-key-lipid-metabolism-related-genes-involved-in-tubular-injury-in-diabetic-kidney-disease-by-bioinformatics-analysis
#13
JOURNAL ARTICLE
Yuanshuo Fan, Juan He, Lixin Shi, Miao Zhang, Ye Chen, Lifen Xu, Na Han, Yuecheng Jiang
AIMS: Accumulating evidences indicate that abnormalities in tubular lipid metabolism play a crucial role in the development of diabetic kidney disease (DKD). We aim to identify novel lipid metabolism-related genes associated with tubular injury in DKD by utilizing bioinformatics approaches. METHODS: Differentially expressed genes (DEGs) between control and DKD tubular tissue samples were screened from the Gene Expression Omnibus (GEO) database, and then were intersected with lipid metabolism-related genes...
May 1, 2024: Acta Diabetologica
https://read.qxmd.com/read/38691149/dual-step-pharmacological-intervention-for-traumatic-like-memories-implications-from-d-cycloserine-and-cannabidiol-or-clonidine-in-male-and-female-rats
#14
JOURNAL ARTICLE
Luciane A Soares, Laura M M Nascimento, Francisco S Guimarães, Lucas Gazarini, Leandro J Bertoglio
RATIONALE: Therapeutic approaches to mitigating traumatic memories have often faced resistance. Exploring safe reconsolidation blockers, drugs capable of reducing the emotional valence of the memory upon brief retrieval and reactivation, emerges as a promising pharmacological strategy. Towards this objective, preclinical investigations should focus on aversive memories resulting in maladaptive outcomes and consider sex-related differences to enhance their translatability. OBJECTIVES: After selecting a relatively high training magnitude leading to the formation of a more intense and generalized fear memory in adult female and male rats, we investigated whether two clinically approved drugs disrupting its reconsolidation remain effective...
May 1, 2024: Psychopharmacology
https://read.qxmd.com/read/38691145/combining-serum-micrornas-and-machine-learning-algorithms-for-diagnosing-infectious-fever-after-hsct
#15
JOURNAL ARTICLE
Wenwei Shao, Yixuan Wang, Li Liu, Yiran Ren, Jieru Wang, Yuqing Cui, Jia Liu, Xiaoyu Zhang, Sudong Zhang, Shuangjie Liu, Erlie Jiang, Sizhou Feng, Xiaolei Pei
Infection post-hematopoietic stem cell transplantation (HSCT) is one of the main causes of patient mortality. Fever is the most crucial clinical symptom indicating infection. However, current microbial detection methods are limited. Therefore, timely diagnosis of infectious fever and administration of antimicrobial drugs can effectively reduce patient mortality. In this study, serum samples were collected from 181 patients with HSCT with or without infection, as well as the clinical information. And more than 80 infectious-related microRNAs in the serum were selected according to the bulk RNA-seq result and detected in the 345 time-pointed serum samples by Q-PCR...
May 1, 2024: Annals of Hematology
https://read.qxmd.com/read/38691107/qualitative-transformations-of-street-seized-ecstasy-over-a-decade-a-case-study-in-rio-de-janeiro-brazil
#16
JOURNAL ARTICLE
Ananda da Silva Antonio, Gleicielle Tozzi Wurzler, Cecília de Andrade Bhering, Adriana Sousa de Oliveira, Luciana Silva do Amaral Cohen, Marco Antônio Martins de Oliveira, Francisco Radler de Aquino Neto, Gabriela Vanini
The illegal drug market is constantly evolving, with new drugs being created and existing ones being modified. Adulterants are often added to the mix, and the primary substance may be secretly replaced by a new one. Once-known tablets can now be vastly different from what they are sold as, all due to the pursuit of profit and evasion of current drug regulations. These alterations in drug composition pose a threat to society, as their effects are still not well understood. Therefore, it is crucial for police intelligence and public health development to obtain the chemical profiles of illicit drugs...
May 1, 2024: Journal of Forensic Sciences
https://read.qxmd.com/read/38691085/the-risk-of-kidney-injury-in-patients-with-sickle-cell-disease-treated-with-ketorolac-for-acute-pain
#17
JOURNAL ARTICLE
Emily M Harris, Morohuntodun O Oni, Carolina Donado, Matthew M Heeney, Jean Solodiuk, Christine Greco, Natasha M Archer
Ketorolac, a nonsteroidal anti-inflammatory drug, is used in combination with opioids to manage vaso-occlusive episodes (VOEs). The relationship between ketorolac use and kidney injury in pediatric patients with sickle cell disease (SCD) remains incompletely understood. We hypothesize that ketorolac is associated with acute kidney injury (AKI) in patients with SCD presenting with pain. All nonsurgical hospitalizations for VOEs treated with ketorolac between January 2014 and December 2022 were included. We used optimal matching methodology to identify control admissions (2:1 ratio) and used nonparametric tests to compare ketorolac administration between cases and controls...
May 1, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38691058/combined-use-of-emapalumab-with-ruxolitinib-and-dexamethasone-as-an-effective-treatment-for-epstein-barr-virus-associated-hemophagocytic-lymphohistiocytosis-complicated-with-multiorgan-damage-and-severe-infection
#18
JOURNAL ARTICLE
Juan Liang, Xiaojun Xu, Zhenjie Chen, Jia Yu, Yongmin Tang
Anti-interferon-γ monoclonal antibody emapalumab and JAK1/2 inhibitors ruxolitinib have been widely reported for the treatment of hemophagocytic lymphohistiocytosis (HLH) recently. These targeted drugs have fewer side effects and may provide new options for patients with HLH who are refractory to previous treatment or intolerant to chemotherapy. Herein, we reported a case of Epstein-Barr virus-related HLH, which did not respond well to HLH-94 plus ruxolitinib and developed severe fungal infection. The disease was successfully controlled after a combination therapy of emapalumab, ruxolitinib, and dexamethasone...
April 26, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38691046/acid-activated-tat-peptide-modified-biomimetic-boron-nitride-nanoparticles-for-enhanced-targeted-codelivery-of-doxorubicin-and-indocyanine-green-a-synergistic-cancer-photothermal-and-chemotherapeutic-approach
#19
JOURNAL ARTICLE
Hui Li, Yuan Fan, Yizhe Shen, Huashan Xu, Huijie Zhang, Fuxue Chen, Shini Feng
The evolution of nano-drug delivery systems addresses the limitations of conventional cancer treatments with stimulus-responsive nanomaterial-based delivery systems presenting temporal and spatial advantages. Among various nanomaterials, boron nitride nanoparticles (BNNs) demonstrate significant potential in drug delivery and cancer treatment, providing a high drug loading capacity, multifunctionality, and low toxicity. However, the challenge lies in augmenting nanomaterial accumulation exclusively within tumors while preserving healthy tissues...
May 1, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38690916/combined-vaccines-against-angiotensin-ii-receptor-type-1-and-alpha-1d-adrenergic-receptor-for-hypertension
#20
JOURNAL ARTICLE
Jiacheng Wu, Zhijie Wu, Wenlong Kuang, Dingyang Shi, Yulu Yang, Xin Li, Jianwu Huang, Xuehan Li, Yuhua Liao, Zihua Zhou, Zhihua Qiu
PURPOSE: Compared with monotherapy, combination therapy with multiple antihypertensive drugs has demonstrated superior efficacy in the management of hypertension. The aim of this study was to explore the efficacy of multitarget combined vaccines in achieving simultaneous antihypertensive and target organ protection effects. METHODS: Our team has developed ATRQβ-001 and ADRQβ-004 vaccines targeting Ang II type 1 receptor (AT1R) and α1D-adrenergic receptor (α1D-AR), respectively...
March 11, 2024: Journal of Hypertension
keyword
keyword
108620
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.